Grace Therapeutics (GRCE) Depreciation & Amortization (CF) (2019 - 2026)
Grace Therapeutics (GRCE) reported Depreciation & Amortization (CF) of $2,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), unchanged from $2,000 a year earlier and unchanged from the prior quarter.
Grace Therapeutics (GRCE) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Grace Therapeutics' Depreciation & Amortization (CF) came in at $7,000, down 12.5% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $7,000, unchanged from FY2025.
- Depreciation & Amortization (CF) has a five-year compound annual growth rate of -45.3% (FY2021 to FY2026).
- By fiscal year, Depreciation & Amortization (CF) came in at $7,000 in FY2025 (-36.4%), $11,000 in FY2024 (-91.1%) and $124,000 in FY2023.
- Five-year quarterly Depreciation & Amortization (CF) spans a low of -$61,000 in fiscal Q2 2023 and a high of $167,000 in fiscal Q1 2023.
- Year over year, Depreciation & Amortization (CF) gained in four of the last seven quarters, with growth averaging 50.0%.
- The high point for year-over-year Depreciation & Amortization (CF) in five years was fiscal Q1 2026 (growth of 100.0%); the low point was fiscal Q1 2024 (a decline of 95.8%).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 534.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.96 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.93 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.11 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 1.62 Bn |
| 10 | Grace Therapeutics | 34.02 Mn | -32.25 Mn | - | 2,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 8,000.00 |
| Dec 31, 2022 | 10,000.00 |
| Sep 30, 2022 | -61,000.00 |
| Jun 30, 2022 | 167,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Sep 30, 2020 | 56,000.00 |
| Jun 30, 2020 | 86,000.00 |
| Mar 31, 2020 | 139,000.00 |
Grace Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();